Frequency and Outcomes of Reduced Dose Non–Vitamin K Antagonist Anticoagulants: Results From ORBIT‐AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II)

BACKGROUND: Non–vitamin K antagonist oral anticoagulants (NOACs) are indicated for stroke prevention in atrial fibrillation (AF) but require lower doses in certain patients. We sought to describe the frequency, appropriateness (according to Food and Drug Administration labeling), and outcomes of pat...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Am Heart Assoc
Main Authors: Steinberg, Benjamin A., Shrader, Peter, Pieper, Karen, Thomas, Laine, Allen, Larry A., Ansell, Jack, Chan, Paul S., Ezekowitz, Michael D., Fonarow, Gregg C., Freeman, James V., Gersh, Bernard J., Kowey, Peter R., Mahaffey, Kenneth W., Naccarelli, Gerald V., Reiffel, James A., Singer, Daniel E., Peterson, Eric D., Piccini, Jonathan P.
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2018
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5850192/
https://ncbi.nlm.nih.gov/pubmed/29453305
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.007633
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker